Please use this identifier to cite or link to this item:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/47389
Full metadata record
???org.dspace.app.webui.jsptag.ItemTag.dcfield??? | Value | Language |
---|---|---|
dc.contributor.advisor | 孫璐西 | |
dc.contributor.author | I-Huei Hou | en |
dc.contributor.author | 侯怡卉 | zh_TW |
dc.date.accessioned | 2021-06-15T05:57:40Z | - |
dc.date.available | 2020-05-30 | |
dc.date.copyright | 2010-08-20 | |
dc.date.issued | 2010 | |
dc.date.submitted | 2010-08-16 | |
dc.identifier.citation | 何承璋。2009。以Aβ聚集導致PC-12細胞氧化損傷之抑制與線蟲壽命延長為模式開發抗氧化與抗老化產品。國立台灣大學食品科技研究所。博士論文。
邱泓智。2009。巴西洋菇萃取物與數種純化合物在PC-12細胞模式中抗阿茲海默症之潛力。國立台灣大學食品科技研究所。碩士論文。 黃蔚婷。2009。以體外Caco-2細胞模式系統探討龍眼花中proanthocyanidin A2 及epicatechin之生物可利用率以及其抗發炎與抗氧化效果。國立台灣大學食品科技研究所。碩士論文。 Akiyama, H.; Barger, S.; Barnum, S.; Bradt, B.; Bauer, J.; Cole, G. M.; Cooper, N. R.; Eikelenboom, P.; Emmerling, M.; Fiebich, B. L.; Finch, C. E.; Frautschy, S.; Griffin, W. S. T.; Hampel, H.; Hull, M.; Landreth, G.; Lue, L.-F.; Mrak, R.; Mackenzie, I. R.; McGeer, P. L.; O'Banion, M. K.; Pachter, J.; Pasinetti, G.; Plata-Salaman, C.; Rogers, J.; Rydel, R.; Shen, Y.; Streit, W.; Strohmeyer, R.; Tooyoma, I.; Van Muiswinkel, F. L.; Veerhuis, R.; Walker, D.; Webster, S.; Wegrzyniak, B.; Wenk, G.; Wyss-Coray, T. Inflammation and Alzheimer's disease. Neurobiol. Aging 2000, 21, 383-421. Alzheimer, A. Über einen eigenartigen schweren Erkrankungsprozeß der Hirnrinde. Neurologisches Zentralblatt 1906, 23, 1129-1136. Arends, M.; Morris, R.; Wyllie, A. Apoptosis. The role of the endonuclease. Am. J. Pathol. 1990, 136, 593-608. Ashkenazi, A.; Dixit, V. M. Death Receptors: Signaling and Modulation. Science 1998, 281, 1305-1308. Ban, J. Y.; Nguyen, H. T. T.; Lee, H. J.; Cho, S. O.; Ju, H. S.; Kim, J. Y.; Bae, K.; Song, K. S.; Seong, Y. H. Neuroprotective Properties of Gallic Acid from Sanguisorbae Radix on Amyloid β Protein (25—35)-Induced Toxicity in Cultured Rat Cortical Neurons. Biol. Pharm. Bull. 2008, 31, 149-153. Barrow, C. J.; Yasuda, A.; Kenny, P. T. M.; Zagorski, M. G. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease : Analysis of circular dichroism spectra. J. Mol. Biol. 1992, 225, 1075-1093. Bastianetto, S.; Quirion, R. Natural extracts as possible protective agents of brain aging. Neurobiol. Aging 2002, 23, 891-897. Bastianetto, S.; Yao, Z. X.; Papadopoulos, V.; Quirion, R. Neuroprotective effects of green and black teas and their catechin gallate esters against β-amyloid-induced toxicity. Eur. J. Neurosci. 2006, 23, 55-64. Begum, A. N.; Jones, M. R.; Lim, G. P.; Morihara, T.; Kim, P.; Heath, D. D.; Rock, C. L.; Pruitt, M. A.; Yang, F.; Hudspeth, B.; Hu, S.; Faull, K. F.; Teter, B.; Cole, G. M.; Frautschy, S. A. Curcumin Structure-Function, Bioavailability, and Efficacy in Models of Neuroinflammation and Alzheimer's Disease. J. Pharmacol. Exp. Ther. 2008, 326, 196-208. Berry, R. W.; Abraha, A.; Lagalwar, S.; LaPointe, N.; Gamblin, T. C.; Cryns, V. L.; Binder, L. I. Inhibition of Tau Polymerization by Its Carboxy-Terminal Caspase Cleavage Fragment. Biochemistry 2003, 42, 8325-8331. Biancalana, M.; Koide, S. Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochimica et Biophysica Acta (BBA) - Proteins & Proteomics 2010, 1804, 1405-1412. Boothby, L. A.; Doering, P. L. Vitamin C and Vitamin E for Alzheimer's Disease. Ann. Pharmacother. 2005, 39, 2073-2079. Brancolini, C.; Lazarevic, D.; Rodriguez, J.; Schneider, C. Dismantling Cell-Cell Contacts during Apoptosis Is Coupled to a Caspase-dependent Proteolytic Cleavage of b-Catenin. J. Cell Biol. 1997, 139, 759-771. Caccamo, A.; Oddo, S.; Billings, L. M.; Green, K. N.; H., M.-C.; Fisher, A.; LaFerla, F. M. M1 Receptors Play a Central Role in Modulating AD-like Pathology in Transgenic Mice Neuron 2006, 671-682. Castellani, R. J.; Zhu, X.; Lee, H.-G.; Smith, M. A.; Perry, G. Molecular Pathogenesis of Alzheimer’s Disease: Reductionist versus Expansionist Approaches. Int. J. Mol. Sci. 2009, 10, 1386-1406 Chang, J. C.; Lai, Y. H.; Djoko, B.; Wu, P. L.; Liu, C. D.; Liu, Y. W.; Chiou, R. Y. Y. Biosynthesis Enhancement and Antioxidant and Anti-inflammatory Activities of Peanut (Arachis hypogaea L.) Arachidin-1, Arachidin-3, and Isopentadienylresveratrol. J. Agric. Food Chem. 2006, 54, 10281-10287. Chen, Q.; Schubert, D. Presenilin-interacting proteins. Expert Rev. Mol. Med. 2002, 4, 1-18. Chong, Z. Z.; Li, F.; Maiese, K. Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease. Brain Res. Rev. 2005, 49, 1-21. Dahlgren, K. N. Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J. Biol. Chem. 2002, 277, 32046-32053. Dichter, M. A.; Tischler, A. S.; Greene, L. A. Nerve growth factor-induced increase in electrical excitability and acetylcholine sensitivity of a rat pheochromocytoma cell line. Nature 1977, 268, 501-504. Djoko, B.; Chiou, R. Y. Y.; Shee, J. J.; Liu, Y. W. Characterization of Immunological Activities of Peanut Stilbenoids, Arachidin-1, Piceatannol, and Resveratrol on Lipopolysaccharide-Induced Inflammation of RAW 264.7 Macrophages. J. Agric. Food Chem. 2007, 55, 2376-2383. Doody, R. S.; Gavrilova, S. I.; Sano, M.; Thomas, R. G.; Aisen, P. S.; Bachurin, S. O.; Seely, L.; Hung, D. Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study. The Lancet 2008, 372, 207-215. Eckert, A.; Keil, U.; Marques, C. A.; Bonert, A.; Frey, C.; Schüssel, K.; Müller, W. E. Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease. Biochemical Pharmacology 2003, 66, 1627-1634. Eriksen, J. L.; Sagi, S. A.; Smith, T. E.; Weggen, S.; Das, P.; McLendon, D. C.; Ozols, V. V.; Jessing, K. W.; Zavitz, K. H.; Koo, E. H.; Golde, T. E. NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo. J. Clin. Investig. 2003, 112, 440-449. Feng, Y.; Wang, X.-p.; Yang, S.-g.; Wang, Y.-j.; Zhang, X.; Du, X.-t.; Sun, X.-x.; Zhao, M.; Huang, L.; Liu, R.-t. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation. NeuroToxicology 2009, 30, 986-995. Fernández, M. A.; Sáenz, M. T.; García, M. D. Anti-inflammatory activity in rats and mice of phenolic acids isolated from Scrophularia frutescens. J. Pharm. Pharmacol. 1998, 50, 1183-1186. Frenkel, D.; Maron, R.; Burt, D. S.; Weiner, H. L. Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears β-amyloid in a mouse model of Alzheimer disease. J. Clin. Invest. 2005, 115, 2423-2433. Gabuzda, D.; Busciglio, J.; Chen, L. B.; Matsudaira, P.; Yankner, B. A. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J. Biol. Chem. 1994, 269, 13623-13628. Gamblin, T. C.; Chen, F.; Zambrano, A.; Abraha, A.; Lagalwar, S.; Guillozet, A. L.; Lu, M.; Fu, Y.; Garcia-Sierra, F.; LaPointe, N.; Miller, R.; Berry, R. W.; Binder, L. I.; Cryns, V. L. Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2003, 100, 10032-10037. Gohil, K.; Lester, P. Global gene expression analysis identifies cell and tissue specific actions of Ginkgo biloba extract, EGb 761. Cell. Mol. Biol. (Oxf.) 2002, 48, 625-31. Gouras, G. K.; Tsai, J.; Naslund, J.; Vincent, B.; Edgar, M.; Checler, F.; Greenfield, J. P.; Haroutunian, V.; Buxbaum, J. D.; Xu, H.; Greengard, P.; Relkin, N. R. Intraneuronal Ab42 Accumulation in Human Brain. Am. J. Pathol. 2000, 156, 15-20. Graf, E. Antioxidant potential of ferulic acid. Free Radic. Biol. Med. 1992, 13, 435-448. Greene, L. A.; Tischler, A. S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. U. S. A. 1976, 73, 2424-2428. Halliwell, B. Reactive Oxygen Species and the Central Nervous System. J. Neurochem. 1992, 59, 1609-1623. Hardy, J.; Selkoe, D. J. The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics. Science 2002, 297, 353-356. Hellström, J. K.; Törrönen, A. R.; Mattila, P. H. Proanthocyanidins in Common Food Products of Plant Origin. J. Agric. Food Chem. 2009, 57, 7899-7906. Hou, R. C. W.; Chen, Y. S.; Chen, C. H.; Chen, Y. H.; Jeng, K. C. G. Protective effect of 1, 2, 4-benzenetriol on LPS-induced NO production by BV2 microglial cells. J. Biomed. Sci. 2006, 13, 89-99. Hsieh, M. C.; Shen, Y. J.; Kuo, Y. H.; Hwang, L. S. Antioxidative Activity and Active Components of Longan (Dimocarpus longan Lour.) Flower Extracts. J. Agric. Food Chem. 2008, 56, 7010-7016. Hsu, D.-Z.; Chen, K.-T.; Li, Y.-H.; Chuang, Y.-C.; Liu, M.-Y. Sesamol Delays Mortality and Attenuates Hepatic Injury After Cecal Ligation and Puncture in Rats: Role of Oxidative Stress. Shock 2006, 25, 528-532. Huang, T. H. J.; Yang, D.-S.; Plaskos, N. P.; Go, S.; Yip, C. M.; Fraser, P. E.; Chakrabartty, A. Structural studies of soluble oligomers of the Alzheimer β-amyloid peptide. J. Mol. Biol. 2000, 297, 73-87. Inoue, M.; Suzuki, R.; Koide, T.; Sakaguchi, N.; Ogihara, Y.; Yabu, Y. Antioxidant, Gallic Acid, Induces Apoptosis in HL-60RG Cells. Biochem. Biophys. Res. Commun. 1994, 204, 898-904. Ireson, C.; Orr, S.; Jones, D. J. L.; Verschoyle, R.; Lim, C.-K.; Luo, J.-L.; Howells, L.; Plummer, S.; Jukes, R.; Williams, M.; Steward, W. P.; Gescher, A. Characterization of Metabolites of the Chemopreventive Agent Curcumin in Human and Rat Hepatocytes and in the Rat in Vivo, and Evaluation of Their Ability to Inhibit Phorbol Ester-induced Prostaglandin E2 Production. Cancer Res. 2001, 61, 1058-1064. Irvine, G. B.; El-Agnaf, O. M.; Shankar, G. M.; Walsh, D. M. Protein Aggregation in the Brain: The Molecular Basis for Alzheimer’s and Parkinson’s Diseases. Mol. Med. 2008, 14, 451-464. Iversen, L. L.; Mortishire-Smith, R. J.; Pollack, S. J.; Shearman, M. S. The toxicity in vitro of beta-amyloid protein. Biochem. J. 1995, 311, 1-16. Jan, K. C.; Ho, C. T.; Hwang, L. S. Elimination and metabolism of sesamol, a bioactive compound in sesame oil, in rats. Mol. Nutr. Food Res. 2009, 53, 36-43. Jang, J.-H.; Surh, Y.-J. Protective effect of resveratrol on b-amyloid-induced oxidative PC12 cell death. Free Radic. Biol. Med. 2003, 34, 1100-1110. Kaltschmidt, B.; Uherek, M.; Volk, B.; Baeuerle, P. A.; Kaltschmidt, C. Transcription factor NF-κB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 1997, 94, 2642-2647. Kaur, I. P.; Saini, A. Sesamol exhibits antimutagenic activity against oxygen species mediated mutagenicity. Mutat. Res. 2000, 470, 71-76. Kern, M.; Fridrich, D.; Reichert, J.; Skrbek, S.; Nussher, A.; Hofem, S.; Vatter, S.; Pahlke, G.; Rüfer, C.; Marko, D. Limited stability in cell culture medium and hydrogen peroxide formation affect the growth inhibitory properties of delphinidin and its degradation product gallic acid. Mol. Nutr. Food Res. 2007, 51, 1163-1172. Klyubin, I.; Betts, V.; Welzel, A. T.; Blennow, K.; Zetterberg, H.; Wallin, A.; Lemere, C. A.; Cullen, W. K.; Peng, Y.; Wisniewski, T.; Selkoe, D. J.; Anwyl, R.; Walsh, D. M.; Rowan, M. J. Amyloid b Protein Dimer-Containing Human CSF Disrupts Synaptic Plasticity: Prevention by Systemic Passive Immunization. J. Neurosci. 2008, 28, 4231-4237. Kroll, S. L.; Czyzyk-Krzeska, M. F. Role of H2O2 and heme-containing O2 sensors in hypoxic regulation of tyrosine hydroxylase gene expression. Am. J. Physiol. Cell Physiol. 1998, 274, 167-174. Kuang, X.; Du, J.-R.; Chen, Y.-S.; Wang, J.; Wang, Y.-N. Protective effect of Z-ligustilide against amyloid [beta]-induced neurotoxicity is associated with decreased pro-inflammatory markers in rat brains. Pharmacol. Biochem. Behav. 2009, 92, 635-641. Kuang, X.; Yao, Y.; Du, J. R.; Liu, Y. X.; Wang, C. Y.; Qian, Z. M. Neuroprotective role of Z-ligustilide against forebrain ischemic injury in ICR mice. Brain Res. 2006, 1102, 145-153. Kuhad, A.; Chopra, K. Effect of sesamol on diabetes-associated cognitive decline in rats. Exp. Brain Res. 2008, 185, 411-420. Ladiwala, A. R. A.; Lin, J. C.; Bale, S. S.; Marcelino-Cruz, A. M.; Bhattacharya, M.; Dordick, J. S.; Tessier, P. M. Resveratrol selectively remodels soluble oligomers and fibrils of amyloid β into off-pathway conformers. J. Biol. Chem. 2010, 1-21. Lannfelt, L.; Blennow, K.; Zetterberg, H.; Batsman, S.; Ames, D.; Harrison, J.; Masters, C. L.; Targum, S.; Bush, A. I.; Murdoch, R.; Wilson, J.; Ritchie, C. W. Safety, efficacy, and biomarker findings of PBT2 in targeting A[beta] as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 2008, 7, 779-786. Laws, S. M.; Hone, E.; Gandy, S.; Martins, R. N. Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. J. Neurochem. 2003, 84, 1215-1236. Levine, H., 3rd. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: Detection of amyloid aggregation in solution. Protein Sci. 1993, 2, 404-410. Lin, M. T.; Beal, M. F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006, 443, 787-795. Lue, L.-F.; Kuo, Y.-M.; Roher, A. E.; Brachova, L.; Shen, Y.; Sue, L.; Beach, T.; Kurth, J. H.; Rydel, R. E.; Rogers, J. Soluble Amyloid {beta} Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease. Am. J. Pathol. 1999, 155, 853-862. Madlener, S.; Illmer, C.; Horvath, Z.; Saiko, P.; Losert, A.; Herbacek, I.; Grusch, M.; Elford, H. L.; Krupitza, G.; Bernhaus, A.; Fritzer-Szekeres, M.; Szekeres, T. Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells. Cancer Lett. 2007, 245, 156-162. Maier, M.; Seabrook, T. J.; Lazo, N. D.; Jiang, L.; Das, P.; Janus, C.; Lemere, C. A. Short Amyloid-beta (Abeta) Immunogens Reduce Cerebral Abeta Load and Learning Deficits in an Alzheimer's Disease Mouse Model in the Absence of an Abeta-Specific Cellular Immune Response. J. Neurosci. 2006, 26, 4717-4728. Maiese, K.; Vincent, A. M. Membrane asymmetry and DNA degradation: functionally distinct determinants of neuronal programmed cell death. J. Neurosci. Res. 2000, 59, 568-580. Mancuso, C.; Bates, T. E.; Butterfield, D. A.; Calafato, S.; Cornelius, C.; Lorenzo, A. D.; Dinkova Kostova, A. T.; Calabrese, V. Natural antioxidants in Alzheimer's disease. Expert Opin. Invest. Drugs 2007, 16, 1921-1931. Mandel, S. A.; Amit, T.; Kalfon, L.; Reznichenko, L.; Weinreb, O.; Youdim, M. B. H. Cell Signaling Pathways and Iron Chelation in the Neurorestorative Activity of Green Tea Polyphenols: Special Reference to Epigallocatechin Gallate (EGCG). J. Alzheimer's Dis. 2008, 15, 211-222. Mangialasche, F.; Solomon, A.; Winblad, B.; Mecocci, P.; Kivipelto, M. Alzheimer's disease: clinical trials and drug development. Lancet Neurol. 2010, 9, 702-716. Matsuoka, Y.; Jouroukhin, Y.; Gray, A. J.; Ma, L.; Hirata-Fukae, C.; Li, H.-F.; Feng, L.; Lecanu, L.; Walker, B. R.; Planel, E.; Arancio, O.; Gozes, I.; Aisen, P. S. A Neuronal Microtubule-Interacting Agent, NAPVSIPQ, Reduces Tau Pathology and Enhances Cognitive Function in a Mouse Model of Alzheimer's Disease. J. Pharmacol. Exp. Ther. 2008, 325, 146-153. Mattson, M. P. Pathways towards and away from Alzheimer's disease. Nature 2004, 430, 631-637. Mazanetz, M. P.; Fischer, P. M. Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases. Nat. Rev. Drug Discovery 2007, 6, 464-479. McShane, R.; Areosa, S. A.; Minakaran, N. Memantine for dementia. Cochrane Database Syst. Rev. 2005, 1-33. Mei, H. F.; Xie, Z. Y.; Zhu, Q. F. The effect of procyanidins on bax and bcl-2 gene expression of apoptosis of PC12 cells induced by β-amyloid peptide(25-35). Chin. J. Gerontol. 2008, 14, 1355-1358. Miller, E. R.; Pastor-Barriuso, R.; Dalal, D.; Riemersma, R. A.; Appel, L. J.; Guallar, E. Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality. Ann. Intern. Med. 2005, 142, 37-46. Mokni, M.; Elkahoui, S.; Limam, F.; Amri, M.; Aouani, E. Effect of Resveratrol on Antioxidant Enzyme Activities in the Brain of Healthy Rat. Neurochem. Res. 2007, 32, 981-987. Moreira, P. I.; Santos, M. S.; Moreno, A.; Rego, A. C.; Oliveira, C. Effect of amyloid β-peptide on permeability transition pore: A comparative study. J. Neurosci. Res. 2002, 69, 257-267. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63. Nishimura, I.; Uetsuki, T.; Kuwako, K.; Hara, T.; Kawakami, T.; Aimoto, S.; Yoshikawa, K. Cell death induced by a caspase-cleaved transmembrane fragment of the Alzheimer amyloid precursor protein. Cell Death Differ. 2002, 9, 199-208. Oakley, H.; Cole, S. L.; Logan, S.; Maus, E.; Shao, P.; Craft, J.; Guillozet-Bongaarts, A.; Ohno, M.; Disterhoft, J.; Van Eldik, L.; Berry, R.; Vassar, R. Intraneuronal beta-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation. J. Neurosci. 2006, 26, 10129-10140. Ono, K.; Condron, M. M.; Ho, L.; Wang, J.; Zhao, W.; Pasinetti, G. M.; Teplow, D. B. Effects of Grape Seed-derived Polyphenols on Amyloid β-Protein Self-assembly and Cytotoxicity. J. Biol. Chem. 2008, 283, 32176-32187. Ono, K.; Hirohata, M.; Yamada, M. Ferulic acid destabilizes preformed [beta]-amyloid fibrils in vitro. Biochem. Biophys. Res. Commun. 2005, 336, 444-449. Osawa, T.; Kato, Y. Protective Role of Antioxidative Food Factors in Oxidative Stress Caused by Hyperglycemia. Ann. N. Y. Acad. Sci. 2005, 1043, 440-451. Pan, M. H.; Huang, T. M.; Lin, J. K. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab. Dispos. 1999, 27, 486-494. Pari, L.; Amali, D. R. Protective role of tetrahydrocurcumin (THC) an active principle of turmeric on chloroquine induced hepatotoxicity in rats. J. Pharm. Pharm. Sci. 2005, 8, 115-123. Peng, H. Y.; Du, J. R.; Zhang, G. Y.; Kuang, X.; Liu, Y. X.; Qian, Z. M.; Wang, C. Y. Neuroprotective effect of Z-ligustilide against permanent focal ischemic damage in rats. Biol. Pharm. Bull. 2007, 30, 309-312. Pereira, C.; Santos, M. S.; Oliveira, C. Mitochondrial function impairment induced by amyloid peptide on PC12 cells. Neuroreport 1998, 9, 1749-1755. Porat, Y.; Abramowitz, A.; Gazit, E. Inhibition of Amyloid Fibril Formation by Polyphenols: Structural Similarity and Aromatic Interactions as a Common Inhibition Mechanism. Chem. Biol. Drug Des. 2006, 67, 27-37. Pugazhenthi, S. Oxidative stress-mediated down-regulation of bcl-2 promoter in hippocampal neurons. J. Neurochem. 2003, 84, 982-996. Querfurth, H. W.; LaFerla, F. M. Alzheimer's Disease. N. Engl. J. Med. 2010, 362, 329-344. Rafii, M.; Aisen, P. Recent developments in Alzheimer's disease therapeutics. BMC Med. 2009, 7, 7-10. Rahman, I.; Biswas, S. K.; Kirkham, P. A. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem. Pharmacol. 2006, 72, 1439-1452. Rapoport, M.; Dawson, H. N.; Binder, L. I.; Vitek, M. P.; Ferreira, A. Tau is essential to β-amyloid-induced neurotoxicity. Proc. Natl. Acad. Sci. U. S. A. 2002, 99, 6364-6369. Rauk, A. Why is the amyloid beta peptide of Alzheimer’s disease neurotoxic? Dalton Trans. 2008, 1273-1282. Reddy, P. H.; McWeeney, S. Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models. Neurobiol. Aging 2006, 27, 1060-1077. Roberson, E. D.; Mucke, L. 100 Years and Counting: Prospects for Defeating Alzheimer's Disease. Science 2006, 314, 781-784. Rohn, T. T.; Vyas, V.; Hernandez-Estrada, T.; Nichol, K. E.; Christie, L.-A.; Head, E. Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the anti-apoptotic protein Bcl-2. J. Neurosci. 2008, 28, 3051-3059. Rossor, M. N.; Fox, N. C.; Freeborough, P. A.; Harvey, R. J. Clinical Features of Sporadic and Familial Alzheimer's Disease. Neurodegeneration 1996, 5, 393-397. Sakono, M.; Zako, T. Amyloid oligomers: formation and toxicity of Ab oligomers. FEBS J. 2010, 277, 1358-1458. Sandur, S. K.; Pandey, M. K.; Sung, B.; Ahn, K. S.; Murakami, A.; Sethi, G.; Limtrakul, P.; Badmaev, V.; Aggarwal, B. B. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 2007, 28, 1765-1773. Saunders, A. M.; Strittmatter, W. J.; Schmechel, D.; St. George-Hyslop, P. H.; Pericak-Vance, M. A.; Joo, S. H.; Rosi, B. L.; Gusella, J. F.; Crapper-MacLachlan, D. R.; Alberts, M. J.; Hulette, C.; Crain, B.; Goldgaber, D.; Roses, A. D. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993, 43, 1467-1472. Schenk, D. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999, 400, 173-177. Schlesier, K.; Harwat, M.; Böhm, V.; Bitsch, R. Assessment of Antioxidant Activity by Using Different In Vitro Methods. Free Radic. Res. 2002, 36, 177-187. Selkoe, D. J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 2001, 81, 741-766. Selkoe, D. J. Soluble oligomers of the amyloid b-protein impair synaptic plasticity and behavior. Behav. Brain Res. 2008, 192, 106-113. Sharma, S.; Kaur, I. P. Development and evaluation of sesamol as an antiaging agent. Int. J. Dermatol. 2006, 45, 200-208. Shimada, K.; Fujikawa, K.; Yahara, K.; Nakamura, T. Antioxidative properties of xanthan on the autoxidation of soybean oil in cyclodextrin emulsion. J. Agric. Food Chem. 1992, 40, 945-948. Siemers, E. R. Effects of a g-secretase inhibitor in a randomized study of patients with Alzheimer disease. Neurology 2006, 66, 602-604. Simons, M.; Keller, P.; De Strooper, B.; Beyreuther, K.; Dotti, C. G.; Simons, K. Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. U. S. A. 1998, 95, 6460-6464. Small, D. H. Alzheimer's disease and the amyloid β protein: what is the role of amyloid? J. Neurochem. 1999, 73, 443. Small, D. H.; Barrow, C. J. Abeta peptide and Alzheimer's disease. 2006, 1-4. Smith, J. V.; Luo, Y. Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761. J. Alzheimer's Dis. 2003, 5, 287-300. Smith, J. V.; Luo, Y. Studies on molecular mechanisms of Ginkgo biloba extract. Appl. Microbiol. Biotechnol. 2004, 64, 465-472. Sobolev, V. S.; Guo, B. Z.; Holbrook, C. C.; Lynch, R. E. Interrelationship of Phytoalexin Production and Disease Resistance in Selected Peanut Genotypes. J. Agric. Food Chem. 2007, 55, 2195-2200. Song, Y. S.; Park, H. J.; Kim, S. Y.; Lee, S. H.; Yoo, H. S.; Lee, H. S.; Lee, M. K.; Oh, K. W.; Kang, S.-K.; Lee, S. E.; Hong, J. T. Protective role of Bcl-2 on [beta]-amyloid-induced cell death of differentiated PC12 cells: reduction of NF-[kappa]B and p38 MAP kinase activation. Neurosci. Res. 2004, 49, 69-80. Spires-Jones, T. L.; Stoothoff, W. H.; de Calignon, A.; Jones, P. B.; Hyman, B. T. Tau pathophysiology in neurodegeneration: a tangled issue. Trends Neurosci. 2009, 32, 150-159. Stephen, S.; Jacobo, M.; Myron, F. W.; Jeffrey, L. C. Disease-modifying therapies in Alzheimer’s disease. J. Alzheimer's Dis. 2008, 4, 65-79. Sticht, H.; Bayer, P.; Willbold, D.; Dames, S.; Hilbich, C.; Beyreuther, K.; Frank, R. W.; Rösch, P. Structure of Amyloid A4-(1-40)-Peptide of Alzheimer's Disease. Eur. J. Biochem. 1995, 233, 293-298. Sultana, R.; Ravagna, A.; Mohmmad-Abdul, H.; Calabrese, V.; Butterfield, D. A. Ferulic acid ethyl ester protects neurons against amyloid beta- peptide(1-42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity. J. Neurochem. 2005, 92, 749-758. Sung, Y. J.; Cheng, C. I.; Chen, C. S.; Huang, H. B.; Huang, F. L.; Wu, P. C.; Shiao, M. S.; Tsay, H. J. Distinct Mechanisms Account for β-Amyloid Toxicity in PC12 and Differentiated PC12 Neuronal Cells. J. Biomed. Sci. 2003, 10, 379-388. Suzukawa, K.; Miura, K.; Mitsushita, J.; Resau, J.; Hirose, K.; Crystal, R.; Kamata, T. Nerve growth factor-induced neuronal differentiation requires generation of Rac1-regulated reactive oxygen species. J. Biol. Chem. 2000, 275, 13175-13178. Thornberry, N. A.; Rano, T. A.; Peterson, E. P.; Rasper, D. M.; Timkey, T.; Garcia-Calvo, M.; Houtzager, V. M.; Nordstrom, P. A.; Roy, S.; Vaillancourt, J. P.; Chapman, K. T.; Nicholson, D. W. A Combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzyme B. J. Biol. Chem. 1997, 272, 17907-17911. Trojanowski, J. Q.; Schmidt, M. L.; Shin, R.-W.; Bramblett, G. T.; Rao, D.; Lee, V. M. Y. Altered Tau and Neurofilament Proteins in Neuro-Degenerative Diseases: Diagnostic Implications for Alzheimer's Disease and Lewy Body Dementias. Brain Pathol. 1993, 3, 45-54. Ueda, K.; Fukui, Y.; Kageyama, H. Amyloid [beta] protein-induced neuronal cell death: neurotoxic properties of aggregated amyloid [beta] protein. Brain Research 1994, 639, 240-244. Varadarajan, S.; Kanski, J.; Aksenova, M.; Lauderback, C.; Butterfield, D. A. Different Mechanisms of Oxidative Stress and Neurotoxicity for Alzheimer‘s Aβ(1−42) and Aβ(25−35). J. Am. Chem. Soc. 2001, 123, 5625-5631. Vincent, A. M.; Maiese, K. Nitric oxide induction of neuronal endonuclease activity in programmed cell death. Exp. Cell Res. 1999, 246, 290-300. Wahrle, S.; Das, P.; Nyborg, A. C.; McLendon, C.; Shoji, M.; Kawarabayashi, T.; Younkin, L. H.; Younkin, S. G.; Golde, T. E. Cholesterol-Dependent [gamma]-Secretase Activity in Buoyant Cholesterol-Rich Membrane Microdomains. Neurobiol. Dis. 2002, 9, 11-23. Wang, J.-Y.; Andrew, Y. C. S.; Yi-Jung, H.; Jia-Yi, W. Oxidative neurotoxicity in rat cerebral cortex neurons: synergistic effects of H2O2 and NO on apoptosis involving activation of p38 mitogen-activated protein kinase and caspase-3. J. Neurosci. Res. 2003, 72, 508-519. Wang, Q.; Xu, J.; Rottinghaus, G. E.; Simonyi, A.; Lubahn, D.; Sun, G. Y.; Sun, A. Y. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res. 2002, 958, 439-447. Watanabe, C. M. H.; Wolffram, S.; Ader, P.; Rimbach, G.; Packer, L.; Maguire, J. J.; Schultz, P. G.; Gohil, K. The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba. Proc. Natl. Acad. Sci. U. S. A. 2001, 98, 6577-6580. Witting, A. Phagocytic Clearance of Apoptotic Neurons by Microglia/Brain Macrophages In Vitro. J. Neurochem. 2000, 75, 1060-1070. Wolfe, K. L.; Liu, R. H. Cellular Antioxidant Activity (CAA) Assay for Assessing Antioxidants, Foods, and Dietary Supplements. J. Agric. Food Chem. 2007, 55, 8896-8907. Wong, G. T. Chronic treatment with the-secretase inhibitor LY-411,575 inhibits-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. J. Biol. Chem. 2004, 279, 12876. Yabe, T.; Hirahara, H.; Harada, N.; Ito, N.; Nagai, T.; Sanagi, T.; Yamada, H. Ferulic acid induces neural progenitor cell proliferation in vitro and in vivo. Neuroscience 2010, 165, 515-524. Yamamoto, T.; Maruyama, W.; Kato, Y.; Yi, H.; Shamoto-Nagai, M.; Tanaka, M.; Sato, Y.; Naoi, M. Selective nitration of mitochondrial complex I by peroxynitrite: involvement in mitochondria dysfunction and cell death of dopaminergic SH-SY5Y cells. J. Neural. Transm. 2002, 109, 1-13. Yan, J. J.; Cho, J. Y.; Kim, H. S.; Kim, K. L.; Jung, J. S.; Huh, S. O.; Suh, H. W.; Kim, Y. H.; Song, D. K. Protection against β-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br. J. Pharmacol. 2001, 133, 89-96. Yankner, B. A.; Dawes, L. R.; Fisher, S.; Villa-Komaroff, L.; Oster-Granite, M. L.; Neve, R. L. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 1989, 245, 417-425. Yao, Z.; Drieub, K.; Papadopoulos, V. The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from β-amyloid-induced cell death by inhibiting the formation of β-amyloid-derived diffusible neurotoxic ligands. Brain Res. 2001, 889, 181-190. Yodkeeree, S.; Garbisa, S.; Limtrakul, P. Tetrahydrocurcumin inhibits HT1080 cell migration and invasion via downregulation of MMPs and uPA. Acta Pharmacol. Sin. 2008, 29, 853-860. Yu, L.; Edalji, R.; Harlan, J. E.; Holzman, T. F.; Lopez, A. P.; Labkovsky, B.; Hillen, H.; Barghorn, S.; Ebert, U.; Richardson, P. L.; Miesbauer, L.; Solomon, L.; Bartley, D.; Walter, K.; Johnson, R. W.; Hajduk, P. J.; Olejniczak, E. T. Structural Characterization of a Soluble Amyloid β-Peptide Oligomer. Biochemistry 2009, 48, 1870-1877. Yu, Y.; Du, J. R.; •, C. Y. W.; Qian, Z. M. Protection against hydrogen peroxide-induced injury by Z-ligustilide in PC12 cells. Exp. Brain Res. 2008, 184, 307-312. Yuan, J.; Yankner, B. A. Apoptosis in the nervous system. Nature 2000, 407, 802-809. Zimmermann, M.; Francesca, C.; Flaminio, C.; Monica Di, L. Ginkgo biloba extract: from molecular mechanisms to the treatment of Alzhelmer's disease. Cell. Mol. Biol. (Oxf.) 2002, 48, 613-23. Zou, W.; Zeng, J.; Zhuo, M.; Xu, W.; Sun, L.; Wang, J.; Liu, X. Involvement of caspase-3 and p38 mitogen-activated protein kinase in cobalt chloride-induced apoptosis in PC12 cells. J. Neurosci. Res. 2002, 67, 837-843. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/47389 | - |
dc.description.abstract | 阿茲海默症 (Alzheimer’s disease, AD) 為一漸進式的神經退化性疾病,常發生於65歲以上的老年人,導致患者記憶喪失及認知衰退。該病症是由於腦部類澱粉胜肽 (β-amlyoid peptide, Aβ) 斑塊的堆積,造成氧化壓力、粒線體失調、突觸萎縮,進而導致腦部功能退化。PC12細胞為一種類似神經細胞的細胞株,能表現如同神經細胞的特性,因此廣泛應用於阿茲海默症及神經相關的研究。
本研究以「Aβ1-40聚集導致naïve PC12 (nPC12) 及differentiated PC12 (dPC12) 細胞死亡之抑制」作為預防阿茲海默症之細胞模式,以銀杏葉萃出物EGb 761做為正控制組,篩選之試驗樣品包括花生芽萃出之arachidin-1、當歸中有效成分ferulic acid及z-ligustilide、廣泛存在植物中的gallic acid、龍眼花中proanthocyanidin A2 (PA2) 、芝麻油中的sesamol及薑黃代謝物tetrahydrocurcumin (THC),目的為篩選出能有效預防或延緩阿茲海默症的天然物。 於nPC12模式中,發現20 - 40 μM (11.5 - 23.1 ppm) 的PA2及0.5 - 2 μM (0.16 - 0.62 ppm) 的arachidin-1可促進nPC12細胞生長,與100 - 200 ppm的EGb 761效果相近,且以40 μM (23.1 ppm) 的PA2及2 μM (0.62 ppm) 的arachidin-1抑制aggAβ1-40毒性效果最好,達顯著差異 (P<0.01),與50 ppm的EGb 761效果相近。經神經生長因子刺激PC12細胞發展成更接近神經細胞的dPC12模式中,以40 μM (23.1 ppm) 的PA2、1 μM (0.31 ppm) 的arachidin-1、20 μM (3.4 ppm) 的gallic acid及10 ppm的50 % z-ligustilide抑制aggAβ1-40毒性效果最好,皆達顯著差異 (P<0.05),其中40 μM (23.1 ppm) 的PA2抑制效果高於50 ppm的EGb 761。從Thioflavin T assay結果發現,四者皆能造成aggAβ1-40的解集,破壞aggAβ1-40的結構,進而降低aggAβ1-40的毒性,達到保護細胞之效果。PA2、arachidin-1及gallic acid在CAA及DPPH assays等抗氧化試驗中展現良好的抗氧化能力。 從實驗結果推測,PA2、arachidin-1及gallic acid能有效降低氧化壓力,並且能破壞aggAβ1-40結構,進而保護細胞;z-ligustilide則可能藉由破壞aggAβ1-40結構及其他途徑而達到保護dPC12細胞對aggAβ1-40之傷害。因此本研究推論,認為PA2、arachidin-1、gallic acid及z-ligustilide具有預防阿茲海默症之潛力。 | zh_TW |
dc.description.abstract | Alzheimer’s disease (AD) is a progressive, neurodegenerative disorder in aged people. AD impairs memory and cognitive skills. The hallmark is accumulation of β-amyloid peptide in the brain, leading to elevated oxidative stress, dysfunction of mitochondrial, synapse loss and leading to destroy brain function. PC12 is a neuronal-like cell line expressed several neurobiological characteristics. PC12 cells have been extensively used as an in vitro model of AD and neuron-related research. Our research is entitled ”Inhibition of aggregated Aβ-induced naïve PC12 (nPC12) and differentiated PC12 (dPC12) cells death” as an in vitro model, by using the standardized extract from the leaves of the Ginkgo biloba extract (EGb 761) as the positive control. To investigate the possible neuroprotective effects of arachidin-1 from peanut second metabolite, ferulic acid and z-ligustilide in Angelica sinensis, naturally occurred of gallic acid, proanthocyanidin A2 from Dimocarpus longan Lour. flowers extract, sesamol from sesame oil and tetrahydrocurcumin (THC) from curcumin metabolite. From our results, 20 - 40 μM (11.5 - 23.1 ppm) PA2 and 0.5 -2 μM (0.16 - 0.62 ppm) arachidin-1 in nPC12 cells could increase cell proliferation, and the efficiency was close to 100 - 200 ppm EGb 761. And 40 μM (23.1 ppm) PA2 and 2 μM (0.62 ppm) arachidin-1showed significant potential protective effect on aggAβ1-40 induced cell death (P<0.01), and the efficiency was close to 50 ppm EGb 761. PC12 was differentiated to dPC12 under the stimulation of nerve growth factor (NGF) and growed neurite-like properties. 40 μM (23.1 ppm) PA2, 1 μM (0.31 ppm) arachidin-1, 20 μM (3.4 ppm) gallic acid and 10 ppm 50 % z-ligustilide in dPC12 cells showed significant potential protective effect on aggAβ1-40 induced cell death (P<0.05), and the efficiency of 40 μM (23.1 ppm) PA2 is better than 50 ppm EGb 761. Arachidin-1, PA2 and gallic acid had strong antioxidant effect in CAA and DPPH assays. Arachidin-1, PA2, gallic acid and z-ligustilide could disaggregate aggAβ1-40 oligomers. The results suggested that arachidin-1, PA2 and gallic acid decreased aggAβ1-40 induced cytotoxicity possibly by decreasing the oxidative stress and disaggregated activity. Z-ligustilide decreased aggAβ1-40 induced cytotoxicity possibly by disaggregated activity and other mechanisms. By these mechanisms, therefore, we suggested that arachidin-1, PA2, gallic acid and z-ligustilide had potential neuroprotective activity against aggAβ1-40 induced cytotoxicity | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T05:57:40Z (GMT). No. of bitstreams: 1 ntu-99-R97641017-1.pdf: 2048218 bytes, checksum: cc3a4745718165523c5fd5e7047d4745 (MD5) Previous issue date: 2010 | en |
dc.description.tableofcontents | 中文摘要 I
英文摘要 III 圖次 VII 表次 VIII 縮寫表 IX 壹、前言 1 貳、文獻整理 2 一、阿茲海默症的病徵 2 二、類澱粉胜肽 (β-amyloid peptide, Aβ) 4 三、脂蛋白元E (Apolipoprotein E, ApoE) 7 四、神經纖維糾結 (Neurofibrillary tangels, NFTs) 8 五、氧化壓力 (Oxidative stress) 9 六、Aβ及氧化壓力對突觸 (synapses) 的影響 14 七、發炎反應 (Inflammation) 16 八、細胞凋亡 (Apoptosis) 17 九、阿茲海默症之治療研究 21 (一) 減少Aβ的產生 21 (二) 清除Aβ 22 (三) 抑制Aβ聚集 24 (四) tau蛋白為目標 24 (五) 神經營養因子 24 (六) 其它 24 十、PC12 25 十一、試驗樣品 26 (一) 銀杏葉萃出物EGb 761 26 (二) Arachidin-1 27 (三) Ferulic acid 29 (四) Gallic acid 29 (五) Proanthocyanidin A2 (PA2) 29 (六) Sesamol 29 (七) Tetrahydrocurcumin 30 (八) Z-ligustilide 30 參、研究目的與實驗架構 33 一、研究目的 33 二、實驗架構Experimental Design 34 肆、材料與方法 35 一、實驗材料 35 二、實驗細胞株 35 三、試劑與試藥 36 (一) 細胞實驗用化學藥品 36 (二) 溶劑 37 (三) 其他藥品 37 四、裝置與儀器設備 38 (一) 一般儀器設備 38 (二) 細胞實驗相關儀器設備 38 (三) 細胞實驗用耗材 39 五、實驗用溶液配方 40 六、樣品製備 41 七、Aβ製備與定量 42 八、細胞實驗方法 43 九、統計分析 49 伍、結果 50 一、製作BSA標準曲線作為Aβ蛋白質含量分析 50 二、AggAβ1-40及試驗樣品對nPC12細胞之毒性以及抗agg Aβ1-40細胞毒殺作用之試驗樣品存活率 50 三、AggAβ1-40及試驗樣品於dPC12細胞毒性以及抗agg Aβ1-40細胞毒殺作用之試驗樣品存活率 53 四、試驗樣品之抗氧化能力實驗 56 五、以Thioflavin T分析試驗樣品對aggAβ1-40的解集能力 58 陸、討論 60 柒、結論 66 捌、參考文獻 78 玖、附錄 90 | |
dc.language.iso | zh-TW | |
dc.title | 數種天然物對於Aβ1-40引起PC12及分化後PC12細胞死亡的保護效果 | zh_TW |
dc.title | Protection of PC12 and differentiated PC12 cells from β-amyloid peptide-induced cell death by some natural compounds in food | en |
dc.type | Thesis | |
dc.date.schoolyear | 98-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 蕭明熙,蕭永基,張基煌,鄭菡若,何其儻 | |
dc.subject.keyword | 阿茲海默症,類澱粉胜肽,氧化壓力,PC12,proanthocyanidin A2,arachidin-1,gallic acid,z-ligustilide, | zh_TW |
dc.subject.keyword | β-amyloid peptide,oxidative stress,PC12,proanthocyanidin A2,arachidin-1,gallic acid,z-ligustilide, | en |
dc.relation.page | 114 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2010-08-18 | |
dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
dc.contributor.author-dept | 食品科技研究所 | zh_TW |
Appears in Collections: | 食品科技研究所 |
Files in This Item:
File | Size | Format | |
---|---|---|---|
ntu-99-1.pdf Restricted Access | 2 MB | Adobe PDF |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.